Zhejiang Jolly Pharmaceutical Co (SZSE:300181) Long-Term Capital Lease Obligation : ¥17 Mil (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Zhejiang Jolly Pharmaceutical Co Long-Term Capital Lease Obligation?

Zhejiang Jolly Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥17 Mil.

Zhejiang Jolly Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2024 (¥17 Mil) to Dec. 2024 (¥18 Mil) but then declined from Dec. 2024 (¥18 Mil) to Mar. 2025 (¥17 Mil).

Zhejiang Jolly Pharmaceutical Co's annual Long-Term Capital Lease Obligation declined from Dec. 2022 (¥22 Mil) to Dec. 2023 (¥17 Mil) but then increased from Dec. 2023 (¥17 Mil) to Dec. 2024 (¥18 Mil).

Zhejiang Jolly Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Zhejiang Jolly Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jolly Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Zhejiang Jolly Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

27.32

24.27

22.13

16.69

18.27

Zhejiang Jolly Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															16.40	17.18	17.20	18.27	17.33

Zhejiang Jolly Pharmaceutical Co (SZSE:300181) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Zhejiang Jolly Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Zhejiang Jolly Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Jolly Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jolly Pharmaceutical Co Ltd (SZSE:300181) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 388 Zhiyuan North Road, Moganshan Economic, Development Zone, Deqing, CHN, 313200

Website

http://www.zuoli.com

Zhejiang Jolly Pharmaceutical Co Ltd is a China-based company engaged in the production and distribution of pharmaceutical products. Its production lines include raw materials, tablets, capsules, particles and frozen dry powder injection. Its products include Wuling powder, Wuling capsule, linglianhua particle, clindamycin phosphate injection and other.

Executives

Shen Ai Ying	Executives
Chen Guo Fen	Executives
Yu You Qiang	Director
Chen Jian	Executives
Zheng Xue Gen	Director
Guo Yin Li	Supervisors
Wang Tao	Executives
Yang Jun De	Director
Chen Rui Xiang	Supervisors
Dong Hong Yu	Directors, executives
Zheng Chao Yi	Directors, executives
Zhu Xiao Ping	Executives
Wu Ying	Securities Affairs Representative

Zhejiang Jolly Pharmaceutical Co Headlines

No Headlines